Skip to content

Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes

Effect of Tadalafil, Sildenafil and Pentoxyfylline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05971667
Enrollment
200
Registered
2023-08-02
Start date
2023-07-30
Completion date
2023-10-30
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF

Keywords

Tadalafil, Sildenafil, pentoxyfylline, frozen embryo transfer

Brief summary

The aim of this study is to investigate the Effect of different vasodilators as Tadalafil, Sildenafil and pentoxyfylline in In vitro Fertilization. In addition, the thickness of endometrium and pregnancies rates of these women will also be examined. All adverse effects of all drugs will be estimated

Detailed description

A prospective randomized clinical study will be conducted in the IVF clinic of the gynecology department of Beni Suef University Hospital, Beni-Suef, Egypt. The study will These patients will be randomized into four groups. The participants will take drugs starting from the end of menstruation cycle till endometrium reach optimal and then will start progesterone 800 mg daily.

Interventions

DRUGtadalafil

tadalafil 10 mg one tablet daily

DRUGSildenafil

sildenafil 20 mg two tablets daily

DRUGpentoxifylline

pentoxifylline 400 mg two tabs daily

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* women having thawed embryos

Exclusion criteria

* hypotension * cardiovascular, hepatic, and renal diseases; * uncontrolled diabetes mellitus; * ovarian cysts; * hyperprolactinemia; * abnormal thyroid functions; * uterine fibroids; * patients taking nitrates; * endometriosis and adenomyosis

Design outcomes

Primary

MeasureTime frameDescription
endometrial thicknesswithin 16 day of menstruationmeasured by transvaginal ultrasound

Secondary

MeasureTime frameDescription
pregnancy rate1 monthnumber of cases positive serum pregnancy test

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026